Ara
Toplam kayıt 4, listelenen: 1-4
Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma?
(Wolters Kluwer Medknow Publications, 2020)
Background: Endometrioid-type endometrial carcinoma is the most common malignancy of the female genital tract in developed countries. The prognosis greatly depends on the grade and stage of the disease. Aims: In some ...
An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats
(Taylor & Francis Ltd, 2020)
The aim of this study is to evaluate the effect of GnRH agonist or GnRH antagonist therapy on bleomycin-administered rats by examining ovarian follicle counts and AMH levels. A total of 30 female Wistar albino rats aged ...
Expressions of p53, KAI1, PTEN and their use as prognostic markers in urothelial carcinoma of the bladder
(Kuwait Medical Assoc, 2020)
Objectives: To determine the expression levels of p53, KAI1, PTEN and their relations with the clinicopathologic parameters in patients with urothelial carcinoma of the bladder Design: Retrospective study Setting: Department ...
A grading dilemma; Gleason scoring system: Are we sufficiently compatible? A multi center study
(Wolters Kluwer Medknow Publications, 2020)
Objective: Gleason scoring is the grading system which strongly predicts the prognosis of prostate cancer. However, even being one of the most commonly used systems, the presence of different interobserver agreement rates ...